These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14700554)

  • 1. Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement.
    Spina LD; Soares DV; Brasil RR; da Silva EM; Lobo PM; Conceição FL; Vaisman M
    Growth Horm IGF Res; 2004 Feb; 14(1):45-51. PubMed ID: 14700554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement.
    Spina LD; Soares DV; Brasil RR; Lobo PM; Lúcia Conceição F; Vaisman M
    Pituitary; 2004; 7(3):123-129. PubMed ID: 16328562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
    Bülow B; Erfurth EM
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.
    Pasarica M; Zachwieja JJ; Dejonge L; Redman S; Smith SR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4265-70. PubMed ID: 17785361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
    Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Pituitary; 2006; 9(2):127-35. PubMed ID: 16944044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.
    Giavoli C; Porretti S; Ronchi CL; Cappiello V; Ferrante E; Orsi E; Arosio M; Beck-Peccoz P
    Metabolism; 2004 Jun; 53(6):740-3. PubMed ID: 15164321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.
    Hwu CM; Kwok CF; Lai TY; Shih KC; Lee TS; Hsiao LC; Lee SH; Fang VS; Ho LT
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3285-92. PubMed ID: 9329355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency.
    Roemmler J; Gockel A; Otto B; Bidlingmaier M; Schopohl J
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):88-95. PubMed ID: 21682757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
    Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
    Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.
    Yuen K; Ong K; Husbands S; Chatelain P; Fryklund L; Gluckman P; Ranke M; Cook D; Rosenfeld R; Wass J; Dunger D
    J Clin Endocrinol Metab; 2002 May; 87(5):1989-95. PubMed ID: 11994330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement.
    Brasil RR; Soares DV; Spina LD; Lobo PM; da Silva EM; Mansur VA; Pinheiro MF; Conceição FL; Vaisman M
    J Endocrinol Invest; 2007 Apr; 30(4):306-12. PubMed ID: 17556867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.